Bruker has entered into a software distribution deal with ImaBiotech to promote and distribute quantinetix software for quantitative MALDI imaging a technique facilitating the direct detection of drugs and metabolites in tissue.
The absolute quantification of MALDI imaging data is associated with the complex matrix (intact tissue) and associated ion suppression, which can be tackled by the development of specially suited quantification methods and dedicated software, Quantinetix.
Bruker MALDI imaging market manager Dr Soren-Oliver Deininger said with the Quantinetix software, the company made MALDI imaging a quantitative technique.
"With this collaboration, we are now able to provide our customers with Quantinetix and complete our MALDI molecular imager solution with true quantification," Deininger added.
ImaBiotech CEO Dr Jonathan Stauber said, "With this worldwide sale agreement, we will offer unparalleled technology to the molecular research community in the pharmaceutical and biomedical industries."
